Skip to content
10-K

Annual Report

Evolutionary Genomics, Inc.

0001553350-20-000255

← back to feed
Filed
Mar 30, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Dec 31, 2019 5.88M sh
Operating Cash Flow FY 2019 · Dec 31, 2018 −$748.84K
Short Term Investments FY 2019 · Dec 31, 2018 $28.2K
Total Liabilities FY 2019 · Dec 31, 2018 $955.45K
Current Assets FY 2019 · Dec 31, 2018 $223.42K
Total Assets FY 2019 · Dec 31, 2018 $4.39M
Sga Expense FY 2019 · Dec 31, 2018 $229.04K
Rd Expense FY 2019 · Dec 31, 2018 $473.99K
Net Income FY 2019 · Dec 31, 2018 −$185.21K
Net Income FY 2019 · Dec 31, 2018 −$1.1M
Net Income FY 2019 · Sep 30, 2018 −$265.3K
Net Income FY 2019 · Jun 30, 2018 −$358.04K
Net Income FY 2019 · Mar 31, 2018 −$290.07K
Operating Income FY 2019 · Dec 31, 2018 −$836.8K
Revenue FY 2019 · Dec 31, 2018 $114.81K
Stockholders Equity FY 2019 · Sep 30, 2018 $564.15K
Stockholders Equity FY 2019 · Jun 30, 2018 $804.8K
Stockholders Equity FY 2019 · Mar 31, 2018 $1.14M
Stockholders Equity FY 2019 · Dec 31, 2017 $1.4M
Cash And Equivalents FY 2019 · Dec 31, 2017 $880.24K